Clinical Trials

44 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT00086957 2017-02-27

Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer

31 enrolled 10 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01404260 2017-01-27

ISCAN

219 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT01203917 2017-01-02

IFUM

Phase 4 Completed

1,060 enrolled 14 charts

Caucasian Patients With EGFR Mutation Positive Advanced NSCLC

NCT00357734 2016-08-30

Iressa Follow-up Trial

14 enrolled 10 charts

BreastThoracic

Breast Neoplasms, Lung Neoplasms

NCT00519077 2016-07-01

Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck

44 enrolled 7 charts

Head & Neck

Carcinoma, Head and Neck Neoplasms, Neoplasms

NCT01530334 2016-02-23

ICARUS

61 enrolled 11 charts

Lung Neoplasms

NCT00770588 2016-02-08

INFORM

Phase 4 Completed

296 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00588445 2016-01-22

Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene

65 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00096486 2016-01-21

Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer

74 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00085566 2016-01-20

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

61 enrolled 8 charts

CNSGenitourinarySarcoma

Brain Neoplasms, Glioblastoma, Prostatic Neoplasms, Central Nervous System Neoplasms, Gliosarcoma

NCT00268346 2016-01-05

Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer

58 enrolled 6 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00479089 2015-11-02

Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer

Phase 2 Terminated

50 enrolled 5 charts

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT01017874 2015-07-08

A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer

236 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT00088907 2015-05-06

Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer

Phase 3 Terminated

270 enrolled 8 charts

Head & Neck

Head and Neck Neoplasms

NCT00054691 2015-03-13

ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin

40 enrolled 6 charts

Dermatologic

Skin Neoplasms

NCT00049543 2015-01-01

Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery

503 enrolled 12 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT00042991 2014-05-28

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

69 enrolled 27 charts

CNSSarcoma

Untreated Childhood Anaplastic Astrocytoma

NCT00057941 2014-05-12

Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer

148 enrolled 7 charts

Breast

Breast Neoplasms

NCT01040780 2014-02-14

ICOGEN

399 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00322452 2013-11-07

IPASS

1,329 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung

NCT00536107 2013-10-01

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Terminated

14 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00824746 2013-02-26

ReGaiN

23 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT00352105 2012-11-05

Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer